Substance / Medication

Rizatriptan benzoate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Comparative assessment of in vitro/in vivo performances of orodispersible electrospun and casting films containing rizatriptan benzoate.
Guo Xiong, Cun Dongmei, Wan Feng et al. · Eur J Pharm Biopharm · 2020
PMID: 32634573Observational
Intranasal spray formulation containing rizatriptan benzoate for the treatment of migraine.
Chokshi Ashish, Vaishya Ravi, Inavolu Rachana et al. · Int J Pharm · 2019
PMID: 31593810Observational
Development and validation of UV spectrophotometric method to study stress degradation behaviour of rizatriptan benzoate.
Amolkumar Kempwade, Ashok Taranalli, Kiran Jadhav · Guang Pu Xue Yu Guang Pu Fen Xi · 2015
PMID: 25993836Observational
Histopathological effects of repeated 14-day administration of rizatriptan benzoate in a nitroglycerin-induced migraine rabbits model.
Al-Saadi Raghad, Mohammed Jawad Zainab Jamal, Khalaf Omar Hussein et al. · Open Vet J · 2025
PMID: 40092178ReviewFull text (PMC)
Meloxicam and Rizatriptan Benzoate.
Am J Health Syst Pharm · 2025
PMID: 40560818Other
Rizatriptan benzoate-loaded dissolving microneedle patch for management of acute migraine therapy.
Zhong Chao, Zhang Xiufeng, Sun Yanfang et al. · J Biomater Appl · 2024
PMID: 38427917Other
Fabrication of an ultra-sensitive electrochemical DNA biosensor based on CT-DNA/NiFeONPs/Au/CPE for detecting rizatriptan benzoate.
Nouri Maedeh, Rahimnejad Mostafa, Najafpour Ghasem et al. · Environ Res · 2023
PMID: 37558112Other
Assessment of nano lipid carrier loaded transdermal patch of rizatriptan benzoate.
Bhattacharyya Sayani, Nanjareddy Lavanya · Drug Metab Bioanal Lett · 2022
PMID: 35794742Other
Formulation and Characterization of Nanostructured Lipid Carriers of Rizatriptan Benzoate-LoadedNasal Gel for Brain Targeting.
Mathure Dyandevi, Ranpise Hemantkumar, Awasthi Rajendra et al. · Assay Drug Dev Technol · 2022
PMID: 35771865Other
Design and optimization of kollicoat ® IR based mucoadhesive buccal film for co-delivery of rizatriptan benzoate and propranolol hydrochloride.
Salehi Sahar, Boddohi Soheil · Mater Sci Eng C Mater Biol Appl · 2019
PMID: 30678908Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Rizatriptan benzoate (substance)
SNOMED CT
108412008
UMLS CUI
C0772420

Clinical Data

This intervention maps to 1 entities in the Healos knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.